Vor Biopharma Inc.
VOR
$16.10
$1.177.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 718.73% | 395.19% | 171.40% | 133.38% | -44.14% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 41.62% | -72.58% | -82.22% | -62.93% | 17.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 862.63% | 359.21% | 348.07% | 952.21% | -41.42% |
| Total Current Assets | 672.25% | 374.69% | 156.31% | 127.05% | -42.01% |
|
|
|||||
| Total Current Assets | 672.25% | 374.69% | 156.31% | 127.05% | -42.01% |
| Net Property, Plant & Equipment | -91.45% | -91.66% | -92.43% | -99.95% | -17.29% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -46.13% | -46.79% | -91.13% | -92.33% | -33.88% |
| Total Assets | 363.58% | 224.81% | 51.94% | 45.05% | -34.56% |
|
|
|||||
| Total Accounts Payable | -72.05% | 240.66% | -32.75% | -66.67% | 60.52% |
| Total Accrued Expenses | 69.57% | 53.30% | 99.66% | 656.46% | 25.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -92.80% | -93.36% | -93.95% | -- | 7.81% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -3.89% | 35.24% | 31.33% | 325.86% | 26.60% |
|
|
|||||
| Total Current Liabilities | -3.89% | 35.24% | 31.33% | 325.86% | 26.60% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -90.07% | -90.15% | -90.22% | -- | -13.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1,419.71% | 1,259.46% | 5,480.73% | 3,832.77% | -1.71% |
|
|
|||||
| Common Stock & APIC | 120.12% | 78.57% | 30.28% | 12.19% | 12.45% |
| Retained Earnings | -180.41% | -152.30% | -574.63% | -417.44% | -31.98% |
| Treasury Stock & Other | -3,169.57% | 86.36% | -82.35% | 120.00% | 126.44% |
| Total Common Equity | -327.68% | -269.98% | -3,150.49% | -1,635.18% | -46.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -327.68% | -269.98% | -3,150.49% | -1,635.18% | -46.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -327.68% | -269.98% | -3,150.49% | -1,635.18% | -46.30% |
|
|
|||||